ARTICLE | Company News

Watson, HRA Pharma sales and marketing update

December 6, 2010 8:00 AM UTC

Watson launched ella ulipristal acetate in the U.S. as an emergency contraceptive to prevent pregnancy within 120 hours (five days) of unprotected intercourse or a contraceptive failure. The wholesale acquisition price (WAP) for the selective progesterone receptor modulator (SPRM) is $35.75 per single-dose 30 mg tablet. ...